TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/6/20 16:05 | 5/4/20 | FENC | Fennec Pharmaceuticals Inc. | A1 | Health | BioPrd | Biological Products, (No Diag | Southpoint Capital Advisors LP | NY | T | P | 500 | 6.25 | 0 | 80 | 2 | 4,077 | I | |||||||||||||||
5/10/10 11:42 | 4/30/10 | AHX | Adherex Technologies Inc | Health | BioPrd | Biological Products, (No Diag | Southpoint Capital Advisors LP | NY | T | P.d | 0 | 0.00 | 0 | 200,000 | 482 | 241,504 | I | ||||||||||||||||
2/23/10 17:04 | 2/22/10 | ADH | Adherex Technologies Inc | Health | BioPrd | Biological Products, (No Diag | Southpoint Capital Advisors LP | NY | T | P.a | 0 | 0.00 | 0 | 0 | 0 | 41,504 | I | ||||||||||||||||
9/10/08 19:34 | 8/27/08 | NEXM | Nexmed Inc | NV | Health | Drug | Pharmaceutical Preparations | Southpoint Capital Advisors LP | NY | T | P.d | 1,609 | 0.2528 | 0 | 6,363 | 3,666 | I | ||||||||||||||||
4/3/07 16:32 | 3/16/07 | LEVP | Lev Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Southpoint Capital Advisors LP | NY | T | P | 84 | 1.80 | 0 | 47 | 0 | 12,354 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |